Brookfield vs CME Group
Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structures, revenue considerations, and competitive positioning to help readers understand differences and similarities. Educational content, not financial advice.
Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structure...
Why It's Moving
Brookfield Stock Slides 6-7% This Week as Analysts Weigh Growth Initiatives Against Near-Term Headwinds
- Analyst price targets suggest meaningful upside potential, with Morgan Stanley projecting $60 and National Bank Financial targeting $59, implying 50%+ upside from current levels—though recent weakness reflects profit-taking after the stock's strong run from its $29 low.
- Brookfield's Q3 2025 results showcased operational resilience, with distributable earnings up 6-18% year-over-year and deployable capital climbing to a record $178 billion, signaling management's ability to deploy capital into high-yield opportunities across its diversified portfolio.
- The company's pending acquisition of the remaining stake in Oaktree and expansion of its wealth solutions platform represent key growth drivers that analysts believe could compound shareholder value, though execution risk and near-term market volatility are tempering investor enthusiasm.
CME Group Reaches Record Highs on Surging Volume, But Valuation Concerns Temper Gains
- February 2026 marked a new monthly average daily volume record of 37.6 million contracts (up 14% year-over-year), with standout performances in energy, agricultural, and micro products—WTI Crude Oil futures ADV jumped 35% and Micro Silver futures surged 865%
- Record 2025 revenue of $6.5 billion and a 28.1 million contract average daily volume demonstrated disciplined pricing power and margin expansion to 69.4% adjusted operating margin, while the company returned over $4 billion in total dividends including a $2.2 billion variable component
- Global uncertainty and geopolitical tensions, including Middle East developments, are driving elevated market volatility and sustained retail trading activity—factors that have supported CME's strong recent performance but may not be sustainable if risk sentiment stabilizes
Brookfield Stock Slides 6-7% This Week as Analysts Weigh Growth Initiatives Against Near-Term Headwinds
- Analyst price targets suggest meaningful upside potential, with Morgan Stanley projecting $60 and National Bank Financial targeting $59, implying 50%+ upside from current levels—though recent weakness reflects profit-taking after the stock's strong run from its $29 low.
- Brookfield's Q3 2025 results showcased operational resilience, with distributable earnings up 6-18% year-over-year and deployable capital climbing to a record $178 billion, signaling management's ability to deploy capital into high-yield opportunities across its diversified portfolio.
- The company's pending acquisition of the remaining stake in Oaktree and expansion of its wealth solutions platform represent key growth drivers that analysts believe could compound shareholder value, though execution risk and near-term market volatility are tempering investor enthusiasm.
CME Group Reaches Record Highs on Surging Volume, But Valuation Concerns Temper Gains
- February 2026 marked a new monthly average daily volume record of 37.6 million contracts (up 14% year-over-year), with standout performances in energy, agricultural, and micro products—WTI Crude Oil futures ADV jumped 35% and Micro Silver futures surged 865%
- Record 2025 revenue of $6.5 billion and a 28.1 million contract average daily volume demonstrated disciplined pricing power and margin expansion to 69.4% adjusted operating margin, while the company returned over $4 billion in total dividends including a $2.2 billion variable component
- Global uncertainty and geopolitical tensions, including Middle East developments, are driving elevated market volatility and sustained retail trading activity—factors that have supported CME's strong recent performance but may not be sustainable if risk sentiment stabilizes
Investment Analysis
Pros
- Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
- The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
- Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.
Considerations
- Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
- Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
- Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.
CME Group
CME
Pros
- CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
- The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
- Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.
Considerations
- CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
- The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
- Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.
Related Market Insights
Complexity Kings: When Opacity Creates Opportunity
Discover Nemo's Complexity Kings Neme. Invest in companies with opaque structures and hidden value, poised for significant returns as economic pressures force simplification.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Complexity Kings: When Opacity Creates Opportunity
Discover Nemo's Complexity Kings Neme. Invest in companies with opaque structures and hidden value, poised for significant returns as economic pressures force simplification.
Aimee Silverwood | Financial Analyst
July 25, 2025
Brookfield (BN) Next Earnings Date
Bank of New York Mellon's next earnings report for Q1 2026 is scheduled for April 16, 2026, with results to be released before market open at approximately 6:30 a.m. Eastern time. A conference call to discuss the results will follow at 11:00 a.m. Eastern time on the same day. Following Q1, the company will report Q2 2026 earnings on July 15, 2026. This earnings schedule reflects BNY's standard quarterly reporting cadence established for the 2026 fiscal year.
CME Group (CME) Next Earnings Date
CME Group will announce its first-quarter 2026 earnings on Wednesday, April 22, 2026, before the market opens. The company will release written highlights and its earnings press release at 6:00 a.m. Central Time, followed by an investor conference call at 7:30 a.m. Central Time where executives will address analyst questions. This earnings report will cover the company's financial performance for Q1 2026.
Brookfield (BN) Next Earnings Date
Bank of New York Mellon's next earnings report for Q1 2026 is scheduled for April 16, 2026, with results to be released before market open at approximately 6:30 a.m. Eastern time. A conference call to discuss the results will follow at 11:00 a.m. Eastern time on the same day. Following Q1, the company will report Q2 2026 earnings on July 15, 2026. This earnings schedule reflects BNY's standard quarterly reporting cadence established for the 2026 fiscal year.
CME Group (CME) Next Earnings Date
CME Group will announce its first-quarter 2026 earnings on Wednesday, April 22, 2026, before the market opens. The company will release written highlights and its earnings press release at 6:00 a.m. Central Time, followed by an investor conference call at 7:30 a.m. Central Time where executives will address analyst questions. This earnings report will cover the company's financial performance for Q1 2026.
Which Baskets Do They Appear In?
Complexity Kings
Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Complexity Kings
Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.
Published: June 17, 2025
Explore BasketBuy BN or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Brookfield vs SMBC Group
A neutral Brookfield vs SMBC Group comparison of business models, financial metrics, and market context to help readers research how each organisation operates.
Brookfield vs Chubb
A neutral, educational comparison of Brookfield Corp and Chubb Corporation, examining business models, financial metrics, and market contexts to guide further research.
Brookfield vs BMO
A neutral Brookfield vs BMO comparison of business models, financial metrics and market context, outlining how each operates and the key differences for researchers.